Literature DB >> 9682367

Global progress in infectious disease control.

A R Hinman.   

Abstract

There is both good news and bad news concerning infectious disease control globally. The good news is that smallpox has been eradicated, eradication of poliomyelitis and guinea worm disease is on track, and many infectious diseases are under effective control in much of the world. The advances are primarily the result of improved sanitation, effective use of vaccines, and introduction and use of specific therapies (whose impact has primarily been on mortality, rather than incidence). The bad news is that infectious diseases are still the leading cause of death world-wide, new diseases are emerging, old diseases are re-emerging, there are ominous interactions between diseases, and antibiotic resistance is emerging as a major problem. There are many promising developments for the future, including new and improved vaccines, new specific therapies, and new strategies to deal with infectious disease. However, unless eradicated, infectious diseases remain a threat and require continuous efforts to be kept under control. Given the ability of infectious agents to evolve, it is certain that the future will also hold new problems and new diseases.

Entities:  

Mesh:

Year:  1998        PMID: 9682367     DOI: 10.1016/s0264-410x(98)80107-2

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  21 in total

1.  Targeted photodynamic therapy of established soft-tissue infections in mice.

Authors:  Faten Gad; Touqir Zahra; Kevin P Francis; Tayyaba Hasan; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2004-02-11       Impact factor: 3.982

Review 2.  Nanowire sensors for multiplexed detection of biomolecules.

Authors:  Bo He; Thomas J Morrow; Christine D Keating
Journal:  Curr Opin Chem Biol       Date:  2008-10       Impact factor: 8.822

Review 3.  Bexsero® chronicle.

Authors:  George Vernikos; Duccio Medini
Journal:  Pathog Glob Health       Date:  2014-10       Impact factor: 2.894

4.  Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.

Authors:  Alexander N O Dodoo; Lorna Renner; Adrianus C van Grootheest; Jerry Labadie; Kwadwo O Antwi-Agyei; Selasie Hayibor; Johannes Addison; Victoria Pappoe; Augustina Appiah-Danquah
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 5.  Nanodevices in diagnostics.

Authors:  Ye Hu; Daniel H Fine; Ennio Tasciotti; Ali Bouamrani; Mauro Ferrari
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011 Jan-Feb

6.  The impact of the H1N1 influenza pandemic on clinical presentations and viral epidemiology of acute respiratory infection in preschool children in Brazil.

Authors:  David W Fawkner-Corbett; Maria Carmo M B Duarte; Katie Rose; Angela Fonceca; Patricia Bezerra; Mark Hopkins; Murilo Britto; Luis E Cuevas; Jailson B Correia; Paul Stephen McNamara
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

7.  The apoptotic signaling pathway activated by Toll-like receptor-2.

Authors:  A O Aliprantis; R B Yang; D S Weiss; P Godowski; A Zychlinsky
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

8.  Rapid identification of nine microorganisms causing acute respiratory tract infections by single-tube multiplex reverse transcription-PCR: feasibility study.

Authors:  B Gröndahl; W Puppe; A Hoppe; I Kühne; J A Weigl; H J Schmitt
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

9.  Eradication of bacteria in suspension and biofilms using methylene blue-loaded dynamic nanoplatforms.

Authors:  Jianfeng Wu; Hao Xu; Wei Tang; Raoul Kopelman; Martin A Philbert; Chuanwu Xi
Journal:  Antimicrob Agents Chemother       Date:  2009-05-04       Impact factor: 5.191

10.  Respiratory viral infections detected by multiplex PCR among pediatric patients with lower respiratory tract infections seen at an urban hospital in Delhi from 2005 to 2007.

Authors:  Preeti Bharaj; Wayne M Sullender; Sushil K Kabra; Kalaivani Mani; John Cherian; Vikas Tyagi; Harendra S Chahar; Samander Kaushik; Lalit Dar; Shobha Broor
Journal:  Virol J       Date:  2009-06-26       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.